SE9603480D0 - Beredningsform för svårlösliga läkemedel - Google Patents

Beredningsform för svårlösliga läkemedel

Info

Publication number
SE9603480D0
SE9603480D0 SE9603480A SE9603480A SE9603480D0 SE 9603480 D0 SE9603480 D0 SE 9603480D0 SE 9603480 A SE9603480 A SE 9603480A SE 9603480 A SE9603480 A SE 9603480A SE 9603480 D0 SE9603480 D0 SE 9603480D0
Authority
SE
Sweden
Prior art keywords
forming
dosage form
gel
soluble drugs
drug
Prior art date
Application number
SE9603480A
Other languages
English (en)
Other versions
SE9603480L (sv
Inventor
Johan Carlfors
Katarina Lindell
Original Assignee
Johan Carlfors
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johan Carlfors filed Critical Johan Carlfors
Priority to SE9603480A priority Critical patent/SE9603480L/sv
Publication of SE9603480D0 publication Critical patent/SE9603480D0/sv
Priority to JP10514594A priority patent/JP2001501194A/ja
Priority to AU44077/97A priority patent/AU4407797A/en
Priority to PCT/SE1997/001592 priority patent/WO1998011874A1/en
Publication of SE9603480L publication Critical patent/SE9603480L/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE9603480A 1996-09-23 1996-09-23 Beredningsform för svårlösliga läkemedel SE9603480L (sv)

Priority Applications (4)

Application Number Priority Date Filing Date Title
SE9603480A SE9603480L (sv) 1996-09-23 1996-09-23 Beredningsform för svårlösliga läkemedel
JP10514594A JP2001501194A (ja) 1996-09-23 1997-09-22 ゲル形成性医薬組成物
AU44077/97A AU4407797A (en) 1996-09-23 1997-09-22 Pharmaceutical composition forming a gel
PCT/SE1997/001592 WO1998011874A1 (en) 1996-09-23 1997-09-22 Pharmaceutical composition forming a gel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9603480A SE9603480L (sv) 1996-09-23 1996-09-23 Beredningsform för svårlösliga läkemedel

Publications (2)

Publication Number Publication Date
SE9603480D0 true SE9603480D0 (sv) 1996-09-23
SE9603480L SE9603480L (sv) 1998-03-24

Family

ID=20404002

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9603480A SE9603480L (sv) 1996-09-23 1996-09-23 Beredningsform för svårlösliga läkemedel

Country Status (4)

Country Link
JP (1) JP2001501194A (sv)
AU (1) AU4407797A (sv)
SE (1) SE9603480L (sv)
WO (1) WO1998011874A1 (sv)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6174524B1 (en) 1999-03-26 2001-01-16 Alcon Laboratories, Inc. Gelling ophthalmic compositions containing xanthan gum
US6261547B1 (en) 1998-04-07 2001-07-17 Alcon Manufacturing, Ltd. Gelling ophthalmic compositions containing xanthan gum
FR2777189B1 (fr) * 1998-04-09 2001-04-06 Chauvin Lab Sa Composition ophtalmique comprenant un beta-bloquant
PT1225898E (pt) 1999-11-01 2003-10-31 Alcon Inc Composicoes farmaceuticas contendo um farmaco antibiotico de fluoroquinolona e goma xantana
AU2001270593A1 (en) 2000-07-28 2002-02-13 Alcon Universal Ltd. Pharmaceutical compositions containing tobramycin and xanthan gum
SE0103369D0 (sv) * 2001-10-09 2001-10-09 Astrazeneca Ab Pharmaceutical formulation
FR2840614B1 (fr) 2002-06-07 2004-08-27 Flamel Tech Sa Polyaminoacides fonctionnalises par de l'alpha-tocopherol et leurs applications notamment therapeutiques
FR2855521B1 (fr) 2003-05-28 2005-08-05 Flamel Tech Sa Polyaminoacides fonctionnalises par au moins un groupement h ydrophobe et leurs applications notamment therapeutiques.
EP2404606A1 (en) * 2003-08-21 2012-01-11 Sucampo AG Ophthalmic compositions comprising a prostaglandin and a viscosity agent
ITPD20040245A1 (it) * 2004-10-08 2005-01-08 Fidia Advanced Biopolymers Srl Biomateriali costituiti da acido ialuronico solfatato e gellano utilizzabili nella prevenzione delle adesioni spinali
FR2876581B1 (fr) 2004-10-20 2007-05-18 Interpharm Dev Composition bioadhesive a liberation programmee
US20090036404A1 (en) * 2007-08-02 2009-02-05 Macleod Steven K Ophthalmic compositions comprising a carboxyl-modified fructan or a salt thereof
US20150099751A1 (en) * 2013-10-07 2015-04-09 King Abdulaziz University In situ gel loaded with phosphodiesterase type v inhibitors nanoemulsion
CN106727276A (zh) * 2015-11-22 2017-05-31 中国人民解放军第三军医大学 原位凝胶制剂及其用途
EP3512522A4 (en) * 2017-09-02 2019-10-30 IVIEW Therapeutics, Inc. IN-SITU-MOMENTARY PHARMACEUTICAL COMPOSITIONS AND USES THEREOF FOR SINUS DISEASES

Also Published As

Publication number Publication date
AU4407797A (en) 1998-04-14
WO1998011874A1 (en) 1998-03-26
SE9603480L (sv) 1998-03-24
JP2001501194A (ja) 2001-01-30

Similar Documents

Publication Publication Date Title
SE9603480L (sv) Beredningsform för svårlösliga läkemedel
ATE235895T1 (de) Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis
ATE264114T1 (de) Zyklodexrinpolymere zum gebrauch als medikamententräger
BR9808888A (pt) Formas de dosagem e método de melhorar disfunção erétil masculina
MXPA05003591A (es) Materiales basados en ciclodextrina, composiciones y usos relacionados a los mismos.
DE60023520D1 (de) Flüssiges hochvisköses system mit gesteuerter freisetzung und medizinische oder chirurgische vorrichtung
BR9405798A (pt) Métodos para liberação in vivo de material biológico e composições úteis dos mesmos
EA200501810A1 (ru) Композиция конъюгированного лекарственного средства
FR2808685B1 (fr) Compositions pharmaceutiques pour administration transdermique d'agents anti-inflammatoires
ATE417604T1 (de) Matrix mit verzögerter freisetzung für hochdosierte unlösliche arzneistoffe
BRPI0015567B8 (pt) composto, composição farmacêutica, forma de unidade de dosagem, uso da composição farmacêutica e método para preparar uma composição farmacêutica
CY1109861T1 (el) Διαδερμικο θεραπευτικο συστημα για την ασθενεια του παρκινσον που προκαλει υψηλα επιπεδα πλασματος της ροτιγοτινης
CY1105849T1 (el) Χρηση αντισηπτικων στην εμπορικη κατασκευη φαρμακευτικου παρασκευασματος προς αποτροπη ή θepαπεια εναντι φλεγμονων εντος του ανθρωπινου σωματος
BR0115965A (pt) Composições farmacêuticas para a liberação oral de agentes farmacologicamente ativos
BR9914360A (pt) N-aralquilaminotetralinas como ligandos para oreceptor neuropeptìdeo yy5
RS50303B (sr) Farmaceutska kompozicija nimesulida sa kontrolisanim oslobađanjem
BR9607234A (pt) Grânulos mucoadesivos uso dos mesmos processo para sua preparação composição farmâceutica e uso da mesma
SE8504945L (sv) Farmaceutiska kompositioner innehallande antracyklinglykosider
CY1108863T1 (el) Φαρμακευτικο σκευασμα εκτεταμενης απελευθερωσης ανεξαρτητης απο το ρη
TR200102107T2 (tr) Tümör nekroz faktör antagonistleri ve endometriozda kullanımları.
TR200101719T2 (tr) Erkeklerde organik ereksiyona bağlı işlev bozukluğunun tedavisi için ilaç imalatında apomorfin kullanımı
EA200600817A1 (ru) Антагонисты в1 рецептора брадикинина (варианты), фармацевтическая композиция, лекарственное средство, способ лечения заболеваний (варианты)
BR0009472A (pt) Antagonistas de lhrh com propriedades desolubilidade aperfeiçoadas
CA2383212A1 (en) Controlled release oral dosage suitable for oral administration
ATE464878T1 (de) Pharmazeutische zusammensetzung zur nasalen anwendung von fentanyl

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 9603480-6